拜耳利伐沙班片价格

(Rivaroxaban) works by selectively acting on coagulation factor

Bayer Healthcare is a leading global innovative pharmaceutical company with more than 50,000 employees. It is always committed to developing, producing and selling innovative products that can improve human health. These products improve people's overall health and quality of life through diagnosis, prevention and treatment of diseases. Bayer's Rivaroxaban tablets have been launched in many countries and regions around the world, including China. Patients in need can currently purchase it at major hospitals in the country. Since the rivaroxaban sold in China is an imported original drug and is relatively expensive, many patients cannot afford it, so they turn their attention overseas.

According to Medical Travel, Rivaroxaban tablets developed and produced by Bayer in Germany are available in two specifications: one is 20mg*28 tablets/box, and the other is 15mg*28 tablets/box, both of which are priced around $400. Domestic patients in need can, on the one hand, go abroad to purchase the required drugs in person, or on the other hand, contact some professional and formal domestic overseas medical service institutions (such as Medical Companion Travel) to obtain purchase channels for the required drugs.

After purchasing the drug, patients should be aware that stopping rivaroxaban early may increase the risk of thromboembolic events. In order to minimize the damage caused by this risk, if the anticoagulant must be stopped early due to pathological bleeding or reasons other than completed treatment, the patient needs to consider giving another anticoagulant. During the medication period, if the patient experiences some other adverse reactions, immediate measures should be taken to treat the symptoms.

Recommended hot articles: /newsDetail/96985.html

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.